These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19100171)

  • 21. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious disease. Drug-resistant TB on the rise.
    Stokstad E
    Science; 2000 Mar; 287(5462):2391. PubMed ID: 10766610
    [No Abstract]   [Full Text] [Related]  

  • 23. [Association of tuberculosis and HIV infection in Brazil].
    Kritski A; Dalcolmo M; del Bianco R; del Melo FF; Pinto WP; Schechther M; Castelo A
    Bol Oficina Sanit Panam; 1995 Jun; 118(6):542-54. PubMed ID: 7626227
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tuberculosis in the 21st centruy].
    Casal M
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):207-8. PubMed ID: 10974762
    [No Abstract]   [Full Text] [Related]  

  • 25. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 26. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
    Alcaide F; Coll P
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scale-up of diagnostics for multidrug resistant tuberculosis.
    Caws M; Ha DT
    Lancet Infect Dis; 2010 Oct; 10(10):656-8. PubMed ID: 20813586
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia.
    Massi MN; Wahyuni S; Halik H; ; Yusuf I; Leong FJ; Dick T; Phyu S
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):489-95. PubMed ID: 21396208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing drug resistance of Mycobacterium tuberculosis in a medical center---what about in Taiwan overall?
    Chiang CY; Kim SJ
    J Formos Med Assoc; 2009 Jan; 108(1):1-3. PubMed ID: 19181601
    [No Abstract]   [Full Text] [Related]  

  • 30. Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009.
    Papaventsis D; Nikolaou S; Karabela S; Ioannidis P; Konstantinidou E; Marinou I; Sainti A; Kanavaki S
    Euro Surveill; 2010 Jul; 15(28):. PubMed ID: 20650053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
    Chen L; Li N; Liu M; Zhang J; Zhang H
    J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tuberculosis: reemerging disease].
    Fiaccadori F
    Ann Ital Med Int; 1996; 11(3):167-9. PubMed ID: 8998261
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.
    Dalcolmo M; Gayoso R; Sotgiu G; D'Ambrosio L; Rocha JL; Borga L; Fandinho F; Braga JU; Arakaki Sanchez D; Dockhorn F; Centis R; Migliori GB
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404651
    [No Abstract]   [Full Text] [Related]  

  • 35. Back to the future: a new 'old' lead for tuberculosis.
    Wright GD
    EMBO Mol Med; 2012 Oct; 4(10):1029-31. PubMed ID: 22987753
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
    Tärnvik A
    Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
    [No Abstract]   [Full Text] [Related]  

  • 38. Practical considerations to implement the shorter regimen to MDR-TB patients in China.
    Liu Q; Sun F; Li Y; Bao J; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Oct; 24(10):1035-1036. PubMed ID: 29730223
    [No Abstract]   [Full Text] [Related]  

  • 39. Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Htwe MM; Win SM; Aye KT; Mon AS; Aung ST; Chang CL; Lee JS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263056
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
    Chien JY; Lai CC; Tan CK; Yu CJ; Hsueh PR
    Clin Infect Dis; 2013 Apr; 56(7):1054-5. PubMed ID: 23175554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.